PMV Pharmaceuticals (PMVP) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts1

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.40

Median Target+257.14%

$5.00

Potential upside vs current price

DCF Value-53.36%

$0.65

Potential downside vs current price

Current Stock Price

$1.40

Median Target+257.14%

$5.00

Potential upside vs current price

DCF Value-53.36%

$0.65

Potential downside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts1

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.40

Median Target+257.14%

$5.00

Potential upside vs current price

DCF Value-53.36%

$0.65

Potential downside vs current price

Current Stock Price

$1.40

Median Target+257.14%

$5.00

Potential upside vs current price

DCF Value-53.36%

$0.65

Potential downside vs current price

PMV Pharmaceuticals, Inc.